Partial resistance of SARS-CoV-2 Delta variants to vaccine-elicited antibodies and convalescent sera
Summary: Highly transmissible SARS-CoV-2 variants identified in India and designated B.1.617, Kappa (B.1.617.1), Delta (B.1.617.2), B.1.618, and B.1.36.29 contain spike mutations L452R, T478K, E484K, E484Q, and N440K located within the spike receptor-binding domain and thus could contribute to incre...
Guardado en:
Autores principales: | Takuya Tada, Hao Zhou, Belinda M. Dcosta, Marie I. Samanovic, Mark J. Mulligan, Nathaniel R. Landau |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4a04efff253c4798a3fb65a02845653c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Convalescent-Phase Sera and Vaccine-Elicited Antibodies Largely Maintain Neutralizing Titer against Global SARS-CoV-2 Variant Spikes
por: Takuya Tada, et al.
Publicado: (2021) -
SARS CoV-2 Delta variant exhibits enhanced infectivity and a minor decrease in neutralization sensitivity to convalescent or post-vaccination sera
por: Alona Kuzmina, et al.
Publicado: (2021) -
B.1.526 SARS-CoV-2 Variants Identified in New York City are Neutralized by Vaccine-Elicited and Therapeutic Monoclonal Antibodies
por: Hao Zhou, et al.
Publicado: (2021) -
Endonuclease-based genotyping of the RBM as a method to track the emergence or evolution of SARS-CoV-2 variants
por: Eva Lopez, et al.
Publicado: (2021) -
Functional differences among the spike glycoproteins of multiple emerging severe acute respiratory syndrome coronavirus 2 variants of concern
por: Qian Wang, et al.
Publicado: (2021)